These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Problems of leprosy relapse in China. Li HY Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169 [TBL] [Abstract][Full Text] [Related]
45. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India. Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978 [TBL] [Abstract][Full Text] [Related]
48. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
49. Persister M. leprae after introductory rifampicin followed by dapsone therapy. Sreevatsa ; Girdhar BK; Desikan KV Lepr India; 1981 Jul; 53(3):350-3. PubMed ID: 7278139 [TBL] [Abstract][Full Text] [Related]
50. Recent trends in chemotherapy of leprosy. Parikh DA; Maniar JK; Parikh AC; Ganapati R J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375 [No Abstract] [Full Text] [Related]
52. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay. Ganapati R; Revankar CR; Naik SS Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206 [TBL] [Abstract][Full Text] [Related]
53. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide. Winsley BE; McDougall AC; Brown KE Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974 [No Abstract] [Full Text] [Related]
54. Polytherapy in multibacillary leprosy patients in Nepal. Samuel NM; Samual S; Fairbairn T; Adiga RB Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403 [No Abstract] [Full Text] [Related]
55. Treating Hansen's disease in developing countries. Jackson T West J Med; 1994 Mar; 160(3):278; author reply 279-80. PubMed ID: 8031394 [No Abstract] [Full Text] [Related]
56. Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978. Lepr India; 1979 Jan; 51(1):115-39. PubMed ID: 449282 [No Abstract] [Full Text] [Related]
57. Drug resistance in Nepali leprosy patients. Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972 [TBL] [Abstract][Full Text] [Related]
58. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
59. [New WHO recommendations for the treatment of leprosy]. Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754 [No Abstract] [Full Text] [Related]
60. Recent advances in the study of the leprosy bacillus. Rees RJ Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]